<PAGE> 1
OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response... 14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. ___)*
CARDIAC PATHWAYS CORPORATION
- -------------------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock, no par value
- -------------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
141408 10 4
- -------------------------------------------------------------------------------
(CUSIP NUMBER)
Check the following box if a fee is being paid with this statement [ ].
(A fee is not required only if the filing person: (1) has a previous statement
on file reporting beneficial ownership of more than five percent of the class
of securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing of this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
SEC 1745 (2-95)
Page 1 of 5 Pages
<PAGE> 2
CUSIP No. 141408 10 4 13G PAGE 2 OF 5 PAGES
--------------------- ----- -----
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mir A. Imran ###-##-####
---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
---------------------------------------------------------------------
3 SEC USE ONLY
---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
---------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 483,333
SHARES --------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH --------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON WITH 483,333
--------------------------------------------------------
8 SHARED DISPOSITIVE POWER
--------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
495,833
---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
Not applicable
---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.3%
---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
<PAGE> 3
CUSIP No. 141408 10 4 Page 3 of 5 Pages
ITEM 1.
(a) NAME OF ISSUER: Cardiac Pathways Corporation
(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
995 Benecia Avenue, Sunnyvale, CA 94086
ITEM 2.
(a) NAME OF PERSON FILING: Mir A. Imran
(b) ADDRESS OF PRINCIPAL OFFICE: 26641 Laurel Lane, Los Altos, CA
94022
(c) CITIZENSHIP: United States
(d) TITLE OF CLASS OF SECURITIES: Common Stock, no par value
(e) CUSIP NUMBER: 141408 10 4
ITEM 3. Not applicable
ITEM 4.
(a) AMOUNT BENEFICIALLY OWNED: 495,833
(b) PERCENT OF CLASS: 5.3%
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) Sole power to vote or to direct the
vote: 483,333
(ii) Shared power to vote or to direct the vote:
(iii) Sole power to dispose or direct the
disposition of: 483,333
(iv) Shared power to dispose or direct the
disposition of:
<PAGE> 4
CUSIP No. 141408 10 4 Page 4 of 5 Pages
ITEM 5. Not applicable
ITEM 6. Not applicable
ITEM 7. Not applicable
ITEM 8. Not applicable
ITEM 9. Not applicable
<PAGE> 5
CUSIP No. 141408 10 4 Page 5 of 5 Pages
ITEM 10. By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired in
the ordinary course of business and were acquired for the
purpose of and do not have the effect of changing or
influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in
any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
January 24, 1997
--------------------------------
Date
/s/Mir A. Imran
---------------------------------
Signature
Mir A. Imran
----------------------------------
Name/Title